Royce & Associates’s Evolv Technologies EVLV Stock Holding History

Royce & Associates’s Portfolio EVLV Stock Details EVLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-597,000	Closed	-$2.42M	–	854
2024 Q3	$2.42M	Hold	597,000	–	–	0.02%	594
2024 Q2	$1.52M	Sell	597,000 -100,000	-14%	-$331K	0.01%	656
2024 Q1	$3.1M	Hold	697,000	–	–	0.03%	570
2023 Q4	$3.29M	Buy	697,000 +150,000	+27%	+$641K	0.03%	574
2023 Q3	$2.66M	Buy	547,000 +50,000	+10%	+$308K	0.03%	608
2023 Q2	$2.98M	Buy	497,000 +168,000	+51%	+$794K	0.03%	605
2023 Q1	$1.03M	Buy	+329,000	New	+$939K	0.01%	759

Other funds holding EVLV

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

DCI

Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECG

Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

KCM

Key Colony Management Little Rock, Arkansas $73.7M AUM 49.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royce & Associates's EVLV Position: Q4 2024 in Review

Royce & Associates sold out of Evolv Technologies (EVLV) in Q4 2024, closing a stake of 597,000 shares — an estimated $2.42M sold.

Royce & Associates first reported a position in EVLV in Q1 2023 and held it in 7 quarters. The position peaked at $3.29M in Q4 2023. 182 funds tracked by Wall St. Rank hold EVLV as of Q4 2024.

Royce & Associates reported no remaining Evolv Technologies position as of Q4 2024 after selling out during the quarter.
Royce & Associates sold 597,000 Evolv Technologies shares in Q4 2024, an estimated $2.42M.
Royce & Associates first reported a position in Evolv Technologies in Q1 2023 and held it in 7 quarters.
Royce & Associates's Evolv Technologies position peaked at $3.29M in Q4 2023.
182 funds tracked by Wall St. Rank held Evolv Technologies as of Q4 2024.

Based on Royce & Associates's 13F filing for Q4 2024, filed 10 Feb 2025.